1887

Abstract

This study characterized the genetic basis of antimicrobial resistance of a number of spp. isolated from humans from 2000 to 2004 in Hiroshima prefecture, Japan. A total of 26 isolates of spp. were included in this study. Antimicrobial susceptibility tests revealed high levels of resistance, especially to ampicillin, streptomycin, trimethoprim, tetracycline, nalidixic acid and ciprofloxacin. PCR and DNA sequencing were used for screening and characterization of antibiotic-resistance determinants. PCR sequencing analysis revealed the presence of only one type of class 1 integron in one isolate of . This class 1 integron was 1904 bp and contained two gene cassettes: a probable esterase/lipase () and , which confers resistance to streptomycin and spectinomycin. Two types of class 2 integron were identified in this study. One was the classic type (2158 bp) and carried the three conserved resistance gene cassettes of the class 2 integron, , and , which confer resistance to trimethoprim, streptothricin and streptomycin/spectinomycin, respectively. This type was detected in both (14 isolates) and (five isolates). The other type was shorter (1313 bp) and carried only two gene cassettes, and . This integron was detected in a single isolate of . PFGE patterns showed limited diversity within clusters of the same species. Furthermore, an extended-spectrum -lactamase gene, , which confers resistance to ampicillin, was characterized in all isolates of except the oldest strain, which was isolated in 2000. Southern blot hybridization and conjugation experiments showed that was located in the chromosome.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.46725-0
2006-12-01
2024-12-06
Loading full text...

Full text loading...

/deliver/fulltext/jmm/55/12/1685.html?itemId=/content/journal/jmm/10.1099/jmm.0.46725-0&mimeType=html&fmt=ahah

References

  1. Ahmed A. M., Shimamoto T. 2004; A plasmid-encoded class 1 integron carrying sat , a putative phosphoserine phosphatase gene and aadA2 from enterotoxigenic Escherichia coli O159 isolated in Japan. FEMS Microbiol Lett 235:243–248 [CrossRef]
    [Google Scholar]
  2. Ahmed A. M., Kawamoto H., Inouye K., Hashiwata Y., Sakaki M., Seno M., Shimamoto T. 2005; Genomic analysis of a multidrug-resistant strain of enterohaemorrhagic Escherichia coli O157 : H7 causing a family outbreak in Japan. J Med Microbiol 54:867–872 [CrossRef]
    [Google Scholar]
  3. Bonnet R., Sampaio J. L. M., Labia R., De Champs C., Sirot D., Chanal C., Sirot J. 2000; A novel CTX-M β -lactamase (CTX-M-8) in cefotaxime-resistant Enterobacteriaceae isolated in Brazil. Antimicrob Agents Chemother 44:1936–1942 [CrossRef]
    [Google Scholar]
  4. Bradford P. A. 2001; Extended-spectrum β -lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 14:933–951 [CrossRef]
    [Google Scholar]
  5. Centers for Disease Control and Prevention 2000 Standardized Molecular Subtyping of Foodborne Bacterial Pathogens by Pulsed-Field Gel Electrophoresis: Training Manual Atlanta: Centers for Disease Control and Prevention;
    [Google Scholar]
  6. Cimons M. 2000; Rapid food-borne pathogen ID system is making a difference. ASM News 66:617–619
    [Google Scholar]
  7. DeLappe N., O'Halloran F., Fanning S., Corbett-Feeney G., Cheasty T., Cormican M. 2003; Antimicrobial resistance and genetic diversity of Shigella sonnei isolates from western Ireland, an area of low incidence of infection. J Clin Microbiol 41:1919–1924 [CrossRef]
    [Google Scholar]
  8. Hanson N. D., Moland E. S., Hossain A., Neville S. A., Gosbell I. B., Thomson K. S. 2002; Unusual Salmonella enterica serotype Typhimurium isolate producing CMY-7, SHV-9 and OXA-30 β -lactamases. J Antimicrob Chemother 49:1011–1014 [CrossRef]
    [Google Scholar]
  9. Hansson K., Sundström L., Pelletier A., Roy P. H. 2002; IntI2 integron integrase in Tn 7 . J Bacteriol 184:1712–1721 [CrossRef]
    [Google Scholar]
  10. Hirose K., Terajima J., Izumiya H., Tamura K., Arakawa E., Takai N., Watanabe H. 2005; Antimicrobial susceptibility of Shigella sonnei isolates in Japan and molecular analysis of S. sonnei isolates with reduced susceptibility to fluoroquinolones. Antimicrob Agents Chemother 49:1203–1205 [CrossRef]
    [Google Scholar]
  11. Kotloff K. L., Winickoff J. P., Ivanoff B., Clemens J. D., Swerdlow D. L., Sansonetti P. J., Adak G. K., Levine M. M. 1999; Global burden of Shigella infections: implications for vaccine development and implementation of control strategies. Bull World Health Organ 77:651–666
    [Google Scholar]
  12. Lee J. C., Oh J. Y., Kim K. S., Jeong Y. W., Cho J. W., Park J. C., Seol S. Y., Cho D. T. 2001; Antimicrobial resistance of Shigella sonnei in Korea during the last two decades. APMIS 109:228–234 [CrossRef]
    [Google Scholar]
  13. Lévesque C., Piché L., Larose C., Roy P. H. 1995; PCR mapping of integrons reveals several novel combinations of resistance genes. Antimicrob Agents Chemother 39:185–191 [CrossRef]
    [Google Scholar]
  14. Livermore D. M. 1995; β -Lactamases in laboratory and clinical resistance. Clin Microbiol Rev 8:557–584
    [Google Scholar]
  15. Mahoney F. J., Farley T. A., Burbank D. F., Leslie N. H., McFarland L. M. 1993; Evaluation of an intervention program for the control of an outbreak of shigellosis among institutionalized persons. J Infect Dis 168:1177–1180 [CrossRef]
    [Google Scholar]
  16. Mammina C., Pontello M., Dal Vecchio A., Nastasi A. The Shigella sonnei Working Group (2005; Identification of Shigella sonnei biotype g isolates carrying class 2 integrons in Italy; (2001 to 2003 J Clin Microbiol 43:2467–2470 [CrossRef]
    [Google Scholar]
  17. McIver C. J., White P. A., Jones L. A., Karagiannis T., Harkness J., Marriott D., Rawlinson W. D. 2002; Epidemic strains of Shigella sonnei biotype g carrying integrons. J Clin Microbiol 40:1538–1540 [CrossRef]
    [Google Scholar]
  18. Murray P. R., Baron E. J., Pfaller M. A., Tenover F. C. Yolken R. H. (editors) 1995 Manual of Clinical Microbiology , 6th edn. Washington DC: American Society for Microbiology;
    [Google Scholar]
  19. National Institute of Infectious Diseases; 2006; Shigellosis, Japan, 2003–2005. Infect Agents Surveillance Rep 27:61–63
    [Google Scholar]
  20. Navia M. M., Gascón J., Vila J. 2005; Analysis of the mechanisms of resistance to several antimicrobial agents in Shigella spp. causing travellers' diarrhoea. Clin Microbiol Infect 11:1044–1047 [CrossRef]
    [Google Scholar]
  21. NCCLS 2002 Performance Standards for Antimicrobial Susceptibility Testing; 12th Informational Supplement . Document M100-S12 Wayne, PA: National Committee for Clinical Laboratory Standards;
    [Google Scholar]
  22. Oh J. Y., Yu H. S., Kim S. K., Seol S. Y., Cho D. T., Lee J. C. 2003; Changes in patterns of antimicrobial susceptibility and integron carriage among Shigella sonnei isolates from southwestern Korea during epidemic periods. J Clin Microbiol 41:421–423 [CrossRef]
    [Google Scholar]
  23. Ozmert E. N., Gokturk B., Yurdakok K., Yalcin S. S., Gur D. 2005; Shigella antibiotic resistance in central Turkey: comparison of the years 1987–1994 and 1995–2002. J Pediatr Gastroenterol Nutr 40:359–362 [CrossRef]
    [Google Scholar]
  24. Pazhani G. P., Sarkar B., Ramamurthy T., Bhattacharya S. K., Takeda Y., Niyogi S. K. 2004; Clonal multidrug-resistant Shigella dysenteriae type 1 strains associated with epidemic and sporadic dysenteries in eastern India. Antimicrob Agents Chemother 48:681–684 [CrossRef]
    [Google Scholar]
  25. Peirano G., Agerso Y., Aarestrup F. M., dos Prazeres Rodrigues D. 2005; Occurrence of integrons and resistance genes among sulphonamide-resistant Shigella spp. from Brazil. J Antimicrob Chemother 55:301–305 [CrossRef]
    [Google Scholar]
  26. Replogle M. L., Fleming D. W., Cieslak P. R. 2000; Emergence of antimicrobial-resistant shigellosis in Oregon. Clin Infect Dis 30:515–519 [CrossRef]
    [Google Scholar]
  27. Rowe-Magnus D. A., Guerout A.-M., Mazel D. 2002; Bacterial resistance evolution by recruitment of super-integron gene cassettes. Mol Microbiol 43:1657–1669 [CrossRef]
    [Google Scholar]
  28. Salam M. A., Bennish M. L. 1991; Antimicrobial therapy for shigellosis. Rev Infect Dis 13:S332–S341 [CrossRef]
    [Google Scholar]
  29. Sambrook J., Russell D. 2001 Molecular Cloning: a Laboratory Manual , 3rd edn. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory;
    [Google Scholar]
  30. Siu L. K., Lo J. Y. C., Yuen K. Y., Chau P. Y., Ng M. H., Ho P. L. 2000; β -Lactamases in Shigella flexneri isolates from Hong Kong and Shanghai and a novel OXA-1-like β -lactamase, OXA-30. Antimicrob Agents Chemother 44:2034–2038 [CrossRef]
    [Google Scholar]
  31. Sivapalasingam S., Nelson J. M., Joyce K., Hoekstra M., Angulo F. J., Mintz E. D. 2006; High prevalence of antimicrobial resistance among Shigella isolates in the United States tested by the National Antimicrobial Resistance Monitoring System from 1999 to 2002. Antimicrob Agents Chemother 50:49–54 [CrossRef]
    [Google Scholar]
  32. Stokes H. W., Hall R. M. 1989; A novel family of potentially mobile DNA elements encoding site-specific gene-integration functions: integrons. Mol Microbiol 3:1669–1683 [CrossRef]
    [Google Scholar]
  33. Tenover F. C., Arbeit R. D., Goering R. V., Mickelsen P. A., Murray B. E., Persing D. H., Swaminathan B. 1995; Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33:2233–2239
    [Google Scholar]
  34. Terajima J., Tamura K., Hirose K., Izumiya H., Miyahara M., Konuma H., Watanabe H. 2004; A multi-prefectural outbreak of Shigella sonnei infections associated with eating oysters in Japan. Microbiol Immunol 48:49–52 [CrossRef]
    [Google Scholar]
  35. Weill F.-X., Demartin M., Tandé D., Espié E., Rakotoarivony I., Grimont P. A. D. 2004; SHV-12-like extended-spectrum- β -lactamase-producing strains of Salmonella enterica serotypes Babelsberg and Enteritidis isolated in France among infants adopted from Mali. J Clin Microbiol 42:2432–2437 [CrossRef]
    [Google Scholar]
  36. White P. A., McIver C. J., Rawlinson W. D. 2001; Integrons and gene cassettes in the Enterobacteriaceae . Antimicrob Agents Chemother 45:2658–2661 [CrossRef]
    [Google Scholar]
  37. World Health Organization 1995 Guidelines for the Control of Epidemics due to Shigella dysenteriae 1 Publication no. WHO/CDR/95.4 Geneva: World Health Organization;
    [Google Scholar]
  38. World Health Organization 2001; Global Strategy for Containment of Antimicrobial Resistance . Publication no. WHO/CDS/CSR/DRS/2001.2a: Geneva: World Health Organization;
    [Google Scholar]
  39. World Health Organization 2005; Shigellosis: disease burden, epidemiology and case management. Wkly Epidemiol Rec 80:94–99
    [Google Scholar]
/content/journal/jmm/10.1099/jmm.0.46725-0
Loading
/content/journal/jmm/10.1099/jmm.0.46725-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error